China’s licensing boom improves worldwide pharma power
The record-breaking BD offer shows the extensive global acknowledgment Beijing’s ingenious possessions are acquiring. China’s pharmaceutical sector is undertaking a seismic change from a distributor of common medications to a significant resource
